Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-02

FDA Approved: CARBOPROST TROMETHAMINE — Original Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' original abbreviated new drug application for carboprost tromethamine, enabling its generic use for obstetric indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)

Snippet

ORIG AP for CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)